BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 28912526)

  • 1. MPZL1 forms a signalling complex with GRB2 adaptor and PTPN11 phosphatase in HER2-positive breast cancer cells.
    Beigbeder A; Chartier FJM; Bisson N
    Sci Rep; 2017 Sep; 7(1):11514. PubMed ID: 28912526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HER2 stabilizes EGFR and itself by altering autophosphorylation patterns in a manner that overcomes regulatory mechanisms and promotes proliferative and transformation signaling.
    Hartman Z; Zhao H; Agazie YM
    Oncogene; 2013 Aug; 32(35):4169-80. PubMed ID: 23027125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The adaptor proteins p66Shc and Grb2 regulate the activation of the GTPases ARF1 and ARF6 in invasive breast cancer cells.
    Haines E; Saucier C; Claing A
    J Biol Chem; 2014 Feb; 289(9):5687-703. PubMed ID: 24407288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple Grb2-mediated integrin-stimulated signaling pathways to ERK2/mitogen-activated protein kinase: summation of both c-Src- and focal adhesion kinase-initiated tyrosine phosphorylation events.
    Schlaepfer DD; Jones KC; Hunter T
    Mol Cell Biol; 1998 May; 18(5):2571-85. PubMed ID: 9566877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noonan syndrome-associated SHP2/PTPN11 mutants cause EGF-dependent prolonged GAB1 binding and sustained ERK2/MAPK1 activation.
    Fragale A; Tartaglia M; Wu J; Gelb BD
    Hum Mutat; 2004 Mar; 23(3):267-77. PubMed ID: 14974085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Grb2 binding induces phosphorylation-independent activation of Shp2.
    Lin CC; Wieteska L; Suen KM; Kalverda AP; Ahmed Z; Ladbury JE
    Commun Biol; 2021 Apr; 4(1):437. PubMed ID: 33795832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct binding of Grb2 SH3 domain to FGFR2 regulates SHP2 function.
    Ahmed Z; George R; Lin CC; Suen KM; Levitt JA; Suhling K; Ladbury JE
    Cell Signal; 2010 Jan; 22(1):23-33. PubMed ID: 19735729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of a novel nonphosphorylated pentapeptide motif displaying high affinity for Grb2-SH2 domain by the utilization of 3'-substituted tyrosine derivatives.
    Song YL; Peach ML; Roller PP; Qiu S; Wang S; Long YQ
    J Med Chem; 2006 Mar; 49(5):1585-96. PubMed ID: 16509576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The multi-site docking protein Grb2-associated binder 1 (Gab1) enhances interleukin-6-induced MAPK-pathway activation in an SHP2-, Grb2-, and time-dependent manner.
    Bongartz H; Gille K; Hessenkemper W; Mandel K; Lewitzky M; Feller SM; Schaper F
    Cell Commun Signal; 2019 Oct; 17(1):135. PubMed ID: 31651330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibronectin-stimulated signaling from a focal adhesion kinase-c-Src complex: involvement of the Grb2, p130cas, and Nck adaptor proteins.
    Schlaepfer DD; Broome MA; Hunter T
    Mol Cell Biol; 1997 Mar; 17(3):1702-13. PubMed ID: 9032297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Signaling adaptor ShcD suppresses extracellular signal-regulated kinase (Erk) phosphorylation distal to the Ret and Trk neurotrophic receptors.
    Wills MK; Keyvani Chahi A; Lau HR; Tilak M; Guild BD; New LA; Lu P; Jacquet K; Meakin SO; Bisson N; Jones N
    J Biol Chem; 2017 Apr; 292(14):5748-5759. PubMed ID: 28213521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heregulin (HRG)-induced mitogenic signaling and cytotoxic activity of a HRG/PE40 ligand toxin in human breast cancer cells.
    Fiddes RJ; Janes PW; Sanderson GM; Sivertsen SP; Sutherland RL; Daly RJ
    Cell Growth Differ; 1995 Dec; 6(12):1567-77. PubMed ID: 9019162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neoplastic transformation induced by insulin receptor substrate-1 overexpression requires an interaction with both Grb2 and Syp signaling molecules.
    Tanaka S; Ito T; Wands JR
    J Biol Chem; 1996 Jun; 271(24):14610-6. PubMed ID: 8662827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyaluronan promotes CD44v3-Vav2 interaction with Grb2-p185(HER2) and induces Rac1 and Ras signaling during ovarian tumor cell migration and growth.
    Bourguignon LY; Zhu H; Zhou B; Diedrich F; Singleton PA; Hung MC
    J Biol Chem; 2001 Dec; 276(52):48679-92. PubMed ID: 11606575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of the Ras signalling pathway in human breast cancer cells overexpressing erbB-2.
    Janes PW; Daly RJ; deFazio A; Sutherland RL
    Oncogene; 1994 Dec; 9(12):3601-8. PubMed ID: 7970720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth inhibition of breast cancer cells by Grb2 downregulation is correlated with inactivation of mitogen-activated protein kinase in EGFR, but not in ErbB2, cells.
    Tari AM; Hung MC; Li K; Lopez-Berestein G
    Oncogene; 1999 Feb; 18(6):1325-32. PubMed ID: 10022814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Grb2 monomer-dimer equilibrium determines normal versus oncogenic function.
    Ahmed Z; Timsah Z; Suen KM; Cook NP; Lee GR; Lin CC; Gagea M; Marti AA; Ladbury JE
    Nat Commun; 2015 Jun; 6():7354. PubMed ID: 26103942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of Grb2/HER2 signaling in Chinese gastric cancer: their relationship with clinicopathological parameters and prognostic significance.
    Yu GZ; Chen Y; Wang JJ
    J Cancer Res Clin Oncol; 2009 Oct; 135(10):1331-9. PubMed ID: 19337752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Global characterization of signalling networks associated with tamoxifen resistance in breast cancer.
    Browne BC; Hochgräfe F; Wu J; Millar EK; Barraclough J; Stone A; McCloy RA; Lee CS; Roberts C; Ali NA; Boulghourjian A; Schmich F; Linding R; Farrow L; Gee JM; Nicholson RI; O'Toole SA; Sutherland RL; Musgrove EA; Butt AJ; Daly RJ
    FEBS J; 2013 Nov; 280(21):5237-57. PubMed ID: 23876235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GRB2 and phospholipase C-gamma 1 associate with a 36- to 38-kilodalton phosphotyrosine protein after T-cell receptor stimulation.
    Sieh M; Batzer A; Schlessinger J; Weiss A
    Mol Cell Biol; 1994 Jul; 14(7):4435-42. PubMed ID: 7516467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.